Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Clinical Trials in China

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University481 Fudan University478 Second Affiliated Hospital, Zhejiang University, School of Medicine401 Ruijin Hospital289 Peking Union Medical College Hospital279
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials in this register

19187 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Lingyi Biotech Co., Ltd.
Early Phase 1
18
Hefei
2026-07-07
Recruiting
AstraZeneca
Phase 3
900
Binzhou, Changsha, Chengdu, Hangzhou, Jinan, Liaocheng, Liuzhou, Luoyang
2026-07-06
Recruiting
AstraZeneca
Phase 3
800
Baotou, Binzhou, Cangzhou, Changsha, Chengdu, Ganzhou, Haikou, Hangzhou
2026-07-06
Recruiting
Lepu Biopharma Co., Ltd.
Phase 2
80
Beijing, Fuzhou, Guangzhou, Shantou, Nanning, Shijiazhuang, Wuhan, Changsha
2026-07-06
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
446
Beijing
2026-07-06
Recruiting
Peking University People's Hospital
Phase 4
500
Beijing
2026-07-06
Not yet open
Dynamic Multimodal Delirium Warning After Cardiac Surgery
NCT07686900Postoperative Delirium, Cardiac Surgical Procedures
Southeast University, China
Observational
200
Nanjing
2026-07-06
Recruiting
Chengdu Suncadia Medicine Co., Ltd.
Phase 2
380
Beijing
2026-07-06
Recruiting
AstraZeneca
Phase 3
1,200
Changsha, Hefei, Huai'an, Langfang, Liangyugang, Luoyang, Nanjing, Nanyang
2026-07-06
Recruiting
AstraZeneca
Phase 3
2,000
Baotou, Beijing, Changde, Changsha, Changzhou, Chengdu, Chenzhou, Chifeng
2026-07-06
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
12
Beijing
2026-07-06
Recruiting
Guangdong Women and Children Hospital
Observational
240
Guangzhou
2026-07-06
Not yet open
Universal STAR-T Cell Injection in Generalized Myasthenia Gravis
NCT07714798Generalized Myasthenia Gravis
Daishi Tian
Phase 1
10
Wuhan
2026-07-06
Not yet open
Survey of Sensory Impairment Indicators Among Adults Aged 65 Years and Older in Xinxing County
NCT07694505Visual Impairment, Hearing Loss, Dual Sensory Impairment, Cataract
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
2,854
Yunfu
2026-07-06
Recruiting
Tingting Yuan
Phase 2
200
Beijing
2026-07-06
Recruiting
Peking University Third Hospital
Not applicable
360
Beijing
2026-07-06
Recruiting
Xiamen Amoytop Biotech Co., Ltd.
Phase 3
84
Anyang, Beijing, Changsha, Chengdu, Chongqing, Dalian, Guangzhou, Hangzhou
2026-07-05
By invitation
The First Hospital of Jilin University
Observational
100
Changchun
2026-07-04
Recruiting
Mindfulness Intervention for Emotional Distress: An EEG Study
NCT07692269Emotional Distress, Anxiety, Depression, Stress (Psychology)
Peking University
Not applicable
160
Beijing
2026-07-04
Recruiting
Hoffmann-La Roche
Phase 3
300
Zhengzhou, Xianyang, Ningbo, Beijing, Changchun, Hefei, Herbin, Huai'an
2026-07-03
By invitation
Jiangsu Chuangyuan Life Science and Technology Co., Ltd.
Phase 1
74
Beijing, Zhengzhou, Nanjing
2026-07-03
Recruiting
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Phase 1
202
Zhengzhou
2026-07-03
Recruiting
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
472
Fuzhou, Zhengzhou, Changsha, Shenyang, Jinan, Hangzhou
2026-07-03
By invitation
Ruijin Hospital
Not applicable
100
Shanghai
2026-07-03
Recruiting
Qilu Hospital of Shandong University
Not applicable
60
Jinan
2026-07-03
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
46
Beijing
2026-07-03
Recruiting
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2
551
Beijing, Jinan
2026-07-03
Recruiting
Second Affiliated Hospital of Nanchang University
Phase 1/2
45
Nanchang
2026-07-03
Recruiting
Shanghai Chest Hospital
Observational
294
Shanghai
2026-07-03
Recruiting
Ruijin Hospital
Not applicable
200
Shanghai
2026-07-02
Recruiting
ShanShan Li
Observational
300
Shenzhen, Huai'an, Suzhou, Xuzhou, Dongying, Shanghai, Changzhou, Jiaozuo
2026-07-02
Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
NCT07476287Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer, Lung Neoplasms
DrugPF-08634404
Pfizer
Phase 2
40
Beijing, Fuzhou, Zhengzhou, Wuhan, Nanchang, Shanghai, Hangzhou
2026-07-02
Recruiting
Nurse-led Integrated Home Service to Support Parents in Symptom Management for Children Requiring Respiratory Support
NCT07652268Children With Medical Complexity (CMC), Symptom Management, Nurse-led Supportive Care, Self Efficacy
Dr Winsome Lam
Not applicable
80
Hong Kong
2026-07-02
By invitation
Novo Nordisk A/S
Observational
216
Beijing, Chongqing, Lanzhou, Jiangmen, Langfang, Harbin, Shiyan, Huai'an
2026-07-02
Active, closed
Hoffmann-La Roche
Phase 1
36
Beijing
2026-07-02
Recruiting
Nanjing Medical University
Not applicable
1,000
Nanjing
2026-07-02
Recruiting
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
300
Guangzhou
2026-07-02
Recruiting
Juventas Cell Therapy Ltd.
Phase 1
9
Tianjin
2026-07-02
Not yet open
Xinqiao Hospital of Chongqing
Phase 4
1,040
Chongqing
2026-07-01
Not yet open
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
13
Hangzhou
2026-07-01
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Phase 2
52
Tianjin
2026-07-01
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Phase 2
30
Nanjing
2026-07-01
Recruiting
Qilu Hospital of Shandong University
Not applicable
274
Xingyi, Yinchuan, Jinan, Linqing
2026-07-01
By invitation
Non-surgical Management After NIT for dMMR/MSI-H GC
NCT07646574Non-surgical Management;dMMR/MSI-H Gastric Cancer;Neoadjuvant Immunotherapy
Yong Zhou
Observational
12
Chengdu
2026-07-01
Not yet open
Gansu Provincial Hospital
Observational
3,000
Lanzhou
2026-07-01
Recruiting
Shanghai Jiao Tong University School of Medicine
Observational
200
Shanghai
2026-07-01
Active, closed
Fudan University
Observational
200
Shanghai
2026-07-01
Not yet open
The First Affiliated Hospital of Soochow University
Phase 4
20
Suzhou
2026-07-01
Not yet open
West China Hospital
Phase 4
110
Chengdu
2026-07-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Early Phase 1
144
Beijing
2026-07-01
Recruiting
Ruijin Hospital
Phase 2
39
Shanghai
2026-07-01
Not yet open
Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC
NCT07697040Esophageal Squamous Cell Carcinoma
DrugBecotatug Vedotin
Hebei Medical University Fourth Hospital
Phase 1
12
Shijiazhuang
2026-07-01
Not yet open
National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China
Early Phase 1
6
Yancheng, Beijing
2026-07-01
Active, closed
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
60
Nanjing
2026-07-01
Recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 1/2
40
Shanghai
2026-07-01
Recruiting
Bo Yan
Not applicable
5,120
Quzhou
2026-07-01
Not yet open
Shear Wave Elastography of Peripheral Nerves for Early Diagnosis of ICU-acquired Weakness
NCT07594249ICU-acquired Weakness, Critical Illness Polyneuropathy, Critical Illness Myopathy
First Affiliated Hospital of Wannan Medical College
Observational
98
Wuhu
2026-07-01
Recruiting
Chinese PLA General Hospital
Early Phase 1
30
Beijing
2026-07-01
Recruiting
Sanofi
Phase 2
30
Shanghai
2026-07-01
Not yet open
First Affiliated Hospital of Zhejiang University
Phase 2
216
Hangzhou
2026-07-01
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
80
Guangzhou
2026-07-01
Recruiting
Xijing Hospital
Phase 2
120
Xi'an
2026-07-01
Recruiting
Women's Hospital School Of Medicine Zhejiang University
Observational
1,500
Hangzhou
2026-07-01
Not yet open
Zishen Yutai Pill for Patients With Recurrent Implantation Failure
NCT07641088Recurrent Implantation Failure
Peking University Third Hospital
Not applicable
878
Hefei, Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Changsha, Nanjing, Xi'an
2026-07-01
Not yet open
Fudan University
Phase 2
189
Shanghai
2026-07-01
Active, closed
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
140
Beijing
2026-07-01
Not yet open
Red Dichromatic Imaging for Improving Post-Biopsy Bronchoscopic Field Visibility
NCT07653945Bronchoscopic Biopsy, Airway Lesion, Biopsy-related Bleeding
First Affiliated Hospital of Ningbo University
Observational
206
Hefei, Zhejiang, Shanghai
2026-07-01
Recruiting
Comparison of Hemodynamics and Respiratory Function Between Ciprofol and Propofol in Elderly Patients Undergoing Non-intubated General Anesthesia
NCT07670923Comparison of Hemodynamics and Respiratory Function Between Ciprofol and Propofol in Elderly Patients Undergoing Non-intubated General Anesthesia
DrugsCiprofol·Propofol
General Hospital of Ningxia Medical University
Phase 4
108
Yinchuan
2026-07-01
Active, closed
Peking Union Medical College
Phase 2
50
Beijing
2026-07-01
Not yet open
Second Hospital of Jilin University
Observational
150
Changchun
2026-07-01
Recruiting
Tang-Du Hospital
Not applicable
500
Xi'an
2026-07-01
Not yet open
Liposomal Amphotericin B for Invasive Fungal Disease in Solid Organ Transplant Recipients
NCT07656493Invasive Fungal Infection, Solid Organ Transplantation, Opportunistic Infections
DrugsAzoles·Echinocandins·Liposomal Amphotericin B
Sichuan Provincial People's Hospital
Observational
120
Chengdu
2026-07-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
274
Beijing
2026-07-01
Not yet open
Shanghai Zhongshan Hospital
Not applicable
60
Shanghai
2026-07-01
Not yet open
Xijing Hospital
Not applicable
98
Xi'an
2026-07-01
Recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
29
Shanghai
2026-07-01
Recruiting
Peking University People's Hospital
Observational
140
Beijing
2026-07-01
Not yet open
AlphaMol Science Ltd. (Shanghai)
Phase 1
48
Beijing
2026-07-01
Not yet open
Sir Run Run Shaw Hospital
Not applicable
212
Hangzhou
2026-07-01
Not yet open
First Affiliated Hospital of Wannan Medical College
Not applicable
20
Wuhu
2026-07-01
Recruiting
Fudan University
Phase 3
636
Shanghai
2026-07-01
Not yet open
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
230
Fuzhou, Xiamen, Foshan, Guangzhou, Shenzhen, Zhongshan, Nanning, Dongguan
2026-07-01
Not yet open
Shanghai Mental Health Center
Not applicable
140
Shanghai
2026-07-01
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
48
Nanjing
2026-07-01
Not yet open
Mental Health Support Interventions for Mothers of Infants and Young Children
NCT07627373Maternal Mental Health, Early Child Development, Depressive Symptoms, Postpartum
Stanford University
Not applicable
440
Shanghai
2026-07-01
Recruiting
Case Management for Microtia
NCT07846345Congenital Microtia
Jing Xu
Not applicable
188
Shanghai
2026-07-01
Not yet open
Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.
NCT07655661Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
DrugsTislelizumab·Capecitabine·Oxaliplatin
Ming Liu
Phase 2
52
Chengdu
2026-07-01
Not yet open
Xuanwu Hospital, Beijing
Not applicable
102
Beijing
2026-07-01
Recruiting
Sun Yat-sen University
Phase 2
103
Guangzhou
2026-07-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
88
Hangzhou
2026-07-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
630
Guangzhou, Wuhan, Nanchang, Shanghai, Chengdu, Hangzhou, Huzhou, Jiaxing
2026-07-01
Not yet open
IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian Cancer
NCT07674615Epithelial Ovarian Cancer, Fallopian Tube Cancers, Primary, Primary Peritoneal Carcinoma
DrugSacituzumab Govitecan
Shanghai Gynecologic Oncology Group
Phase 1
19
Shanghai
2026-07-01
Not yet open
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
NCT07667517Albuminuria, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Diseases
DrugFinerenone
First Affiliated Hospital of Zhejiang University
Phase 4
148
Chongqing, Fuzhou, Foshan, Guangzhou, Nantong, Suqian, Suzhou, Xi'an
2026-07-01
Not yet open
Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection
NCT07593833Ovarian Neoplasms, Ovarian Cancer, Early Detection of Cancer
Tongji Hospital
Observational
1,000
Wuhan
2026-07-01
Recruiting
Robot-Assisted Closed Reduction and Internal Fixation for Distal Femoral Fractures
NCT07738406Supracondylar Femoral Fractures, Femoral Fractures
Beijing Jishuitan Hospital
Not applicable
80
Beijing
2026-07-01
Recruiting
AI-Driven Metabolic Cohort in Overweight/Obese Chinese Adults
NCT07584330Overweight and Obesity, Diabetes Mellitus, Type 2, Prediabetic State, Metabolic Syndrome
Zhujiang Hospital
Observational
2,800
Guangzhou
2026-07-01
Not yet open
Anhui Medical University
Not applicable
75
Hefei
2026-07-01
Recruiting
Beijing Jishuitan Hospital
Not applicable
60
Beijing
2026-07-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
91
Beijing
2026-07-01
Not yet open
The Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation in Individuals With Tiletamine Use Disorder
NCT07689981Tiletamine Use Disorder, Substance Use Disorder (SUD), Drug Craving
Shanghai Mental Health Center
Not applicable
30
Shanghai
2026-07-01
Not yet open
Key Diagnostic & Therapeutic Technologies for Severe Acute High Altitude Disease (SAHAD): Integration and Application
NCT07639931Severe High Altitude Pulmonary Edema, Severe High Altitude Cerebral Edema
Tibet Autonomous Region People's Hospital
Not applicable
3,035
Lhasa
2026-07-01
Not yet open
Sun Yat-sen University
Phase 2
30
Guangzhou
2026-07-01
Recruiting
Xuanwu Hospital, Beijing
Early Phase 1
5
Beijing
2026-07-01
Not yet open
Sun Yat-sen University
Phase 3
296
Guangzhou
2026-07-01
Not yet open
Shanghai Zhongshan Hospital
Phase 4
476
Shanghai
2026-07-01
Not yet open
Mesenteric Vein Access for OPVT-Related Recurrent Variceal Bleeding: An Ambispective Cohort
NCT07666256Occlusive Portal Vein Thrombosis (OPVT), Cavernous Transformation of Portal Vein, Gastroesophageal Varices Bleeding
Air Force Military Medical University, China
Not applicable
15
Xi'an
2026-07-01
Not yet open
Eighth Affiliated Hospital, Sun Yat-sen University
Phase 1
40
Shenzhen
2026-07-01
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
120
Guangzhou
2026-07-01
Recruiting
Shanghai General Hospital, China
Not applicable
120
Shanghai
2026-07-01
Not yet open
Children's Hospital of Fudan University
Not applicable
200
Xiamen, Guangzhou, Zhengzhou, Jinan, Shanghai
2026-07-01
Not yet open
Anti-Bloating Patch for Postoperative Gastric Distension After Cardiac Surgery
NCT07677423Postoperative Gastric Distension, Postoperative Gastrointestinal Dysfunction, Cardiac Surgery
Southeast University, China
Not applicable
150
Nanjing
2026-07-01
Recruiting
Directional PSA Versus STN DBS for TD-PD
NCT07700862Parkinsons Disease (PD)
Ruijin Hospital
Not applicable
32
Shanghai
2026-07-01
Recruiting
Sixth Affiliated Hospital, Sun Yat-sen University
Not applicable
23
Guangzhou
2026-07-01
Not yet open
Case-Based Learning for Bedside Lung Ultrasound Teaching in ICU
NCT07594470Medical Education, ICU, Emergency Medicine, Lung Ultrasound
First Affiliated Hospital of Wannan Medical College
Not applicable
106
Wuhu
2026-07-01
Not yet open
Nanjing University
Not applicable
50
Nanjing
2026-07-01
By invitation
Acupuncture to Prevent Nausea and Vomiting After Stem Cell Transplant
NCT07747194Chemotherapy-Induced Nausea and Vomiting (CINV), Hematopoietic Stem Cell Transplantation (HSCT)
Xiao Wang
Not applicable
80
Chengdu
2026-07-01
Not yet open
Gan & Lee Pharmaceuticals.
Phase 1
64
Linyi
2026-07-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
1,200
Beijing
2026-07-01
Not yet open
Southwest Hospital, China
Not applicable
296
Chongqing
2026-07-01
Not yet open
BeBetter Med Inc
Phase 2
120
Guangzhou, Xi’an, Tianjin
2026-07-01
Recruiting
Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment
NCT07643363Amnestic Mild Cognitive Impairment - aMCI, AD-MCI, AD - Alzheimer's Disease, FTD
Tianjin Huanhu Hospital
Not applicable
60
Tianjin
2026-07-01
Recruiting
Robot-Assisted Closed Reduction and Internal Fixation for Intertrochanteric Femoral Fractures
NCT07738458Intertrochanteric Fractures, Intertrochanteric Fractures of the Hip, Intertrochanteric Fractures of the Femur
Beijing Jishuitan Hospital
Not applicable
60
Beijing
2026-07-01
Not yet open
Shen yang
Phase 2
148
Shanghai
2026-07-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
300
Beijing, Shenzhen, Taiyuan
2026-07-01
Not yet open
Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response
NCT07670715Locally Advanced Non-small Cell Lung Cancer (NSCLC), Thoracic Radiotherapy, Immune Checkpoint Inhibitors, Neoadjuvant Chemoimmunotherapy
Tianjin Medical University Cancer Institute and Hospital
Phase 2
30
Tianjin
2026-07-01
Not yet open
Machine Learning-Guided LIV Selection for Adolescent Idiopathic Scoliosis
NCT07723053Adolescent Idiopathic Scoliosis, Lenke Type 1 Adolescent Idiopathic Scoliosis, Lenke Type 5 Adolescent Idiopathic Scoliosis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
300
Nanjing
2026-07-01
Not yet open
Ruijin Hospital
Phase 1
30
Shanghai
2026-07-01
Not yet open
The Effect of Liposomal Bupivacaine Erector Spinae Plane Block
NCT07667439Liposome Bupivacaine, Erector Spinae Plane Block, Postoperative Analgesia, Randomized Controlled Trial
DrugsBupivacaine Hydrochloride·Liposomal bupivacaine
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
148
Hangzhou
2026-07-01
Recruiting
Zhiliang Gao
Observational
400
Guangzhou
2026-07-01
Not yet open
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 4
20
Nanjing
2026-07-01
Not yet open
Guangzhou Concord Cancer Center
Not applicable
504
Guangzhou
2026-07-01
Recruiting
Beijing Anzhen Hospital
Not applicable
136
Beijing
2026-07-01
Recruiting
Nanjing Children's Hospital
Not applicable
140
Nanjing
2026-07-01
Not yet open
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
1,100
Shanghai
2026-07-01
Active, closed
China Dizziness and Vertigo Cohort Study （VERIDICAL STUDY）
NCT07778901Vertigo, Vestibular Diseases
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
6,000
Hangzhou
2026-07-01
Not yet open
Zhongshan Hospital (Xiamen), Fudan University
Phase 2
15
Xiamen
2026-07-01
Active, closed
Efficacy and Accuracy of an AI-Driven Sleep Earbud for Chronic Insomnia
NCT07744581Insomnia, Insomnia Chronic, Insomnia Disorders, Sleep Wake Disorders
The Chinese University of Hong Kong, Shenzhen
Not applicable
25
Shenzhen
2026-07-01
Not yet open
RenJi Hospital
Phase 4
124
Shanghai
2026-07-01
Not yet open
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
142
Guangzhou
2026-07-01
Not yet open
Nanfang Hospital, Southern Medical University
Observational
2,000
Guangzhou
2026-07-01
Not yet open
Efficacy of Probiotics for OAB Patients With Anxiety
NCT07635212Overactive Bladder (OAB)
Qilu Hospital of Shandong University
Not applicable
218
Jinan
2026-07-01
Not yet open
Fujian Provincial Hospital
Not applicable
106
Fuzhou
2026-07-01
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2
108
Nanjing, Hangzhou, Ha’erbin, Huai'an, Zhengzhou
2026-07-01
Not yet open
Air Force Military Medical University, China
Observational
220
Xi'an
2026-07-01
Recruiting
Zhejiang Cancer Hospital
Observational
50
Hangzhou
2026-07-01
Not yet open
LanZhou University
Not applicable
50
Lanzhou
2026-07-01
Not yet open
Shengjing Hospital
Not applicable
54
Shenyang
2026-07-01
Recruiting
Robot-Assisted Closed Reduction and Internal Fixation for Femoral Shaft Fractures
NCT07738380Femoral Shaft Fractures, Femur Fractures, Femur Fracture
Beijing Jishuitan Hospital
Not applicable
80
Beijing
2026-07-01
Recruiting
Peking Union Medical College Hospital
Phase 2
40
Beijing
2026-07-01
Not yet open
Vascular Aging and Acute Kidney Injury After Cardiac Surgery
NCT07727772Acute Kidney Injury Cardiac Surgery, Postoperative Complications, Vascular Aging
Nanjing First Hospital, Nanjing Medical University
Observational
472
Nanjing
2026-07-01
Not yet open
Chinese PLA General Hospital
Not applicable
150
Beijing
2026-07-01
Not yet open
Dietary Pattern Intervention for Neurodevelopment in Preterm Infants
NCT07702734Preterm, Neurodevelopmental Disorders, Dysbiosis
Fudan University
Not applicable
116
Shanghai
2026-07-01
Not yet open
Sun Yat-sen University
Not applicable
68
Shenzhen
2026-07-01
Not yet open
Early Electroacupuncture for Post-TURP LUTS
NCT07736807Benign Prostatic Hyperplasia
Zhongda Hospital
Not applicable
144
Nanjing
2026-07-01
Not yet open
The First Affiliated Hospital of Guangzhou Medical University
Observational
100
Guangzhou
2026-07-01
Not yet open
Ruijin Hospital
Not applicable
138
Shanghai
2026-07-01
Recruiting
Zhiquan Hu
Phase 3
170
Hefei, Fuzhou, Xiamen, Guangzhou, Shenzhen, Enshi, Huanggang, Huangshi
2026-07-01
Recruiting
Nanfang Hospital, Southern Medical University
Not applicable
106
Guangzhou
2026-07-01
Recruiting
Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer
NCT07689851Gastric Cancer (GC), Gastroesophageal Junction Adenocarcinoma
DrugRetlirafusp alfa
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
60
Shenzhen, Taiyuan, Beijing
2026-07-01
Not yet open
A Multicenter Clinical Study on Protein Absorption Efficiency in Patients With Pancreatic Exocrine Insufficiency in the ICU
NCT07709611High-risk Patients With Pancreatic Exocrine Insufficiency, Enteral Nutrition Feeding
Shanghai 10th People's Hospital
Phase 4
250
Shanghai
2026-07-01
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Early Phase 1
19
Nanjing
2026-07-01
Recruiting
manxiaxia
Not applicable
52
Changchun
2026-07-01
Recruiting
Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBC
NCT07797218Breast Cancer Early Stage Breast Cancer (Stage 1-3)
DrugsHerceptin·Pyrotinib·Pertuzumab·Trastuzumab
Shanghai Jiao Tong University School of Medicine
Phase 3
220
Shanghai
2026-07-01
Not yet open
Thulium Laser Enucleation With Bladder Neck Incision for Small-Volume Benign Prostatic Hyperplasia
NCT07569874Benign Prostatic Hyperplasia, Bladder Outlet Obstruction, Lower Urinary Tract Symptoms (LUTS)
Chinese PLA General Hospital
Not applicable
932
Beijing
2026-07
Not yet open
SYH2095 for Advanced Malignant Tumors: Phase I Study
NCT07692776Advanced Malignant Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Observational
140
Tianjin
2026-07
Not yet open
Chengdu Suncadia Medicine Co., Ltd.
Phase 1
74
Changchun
2026-07
Not yet open
Yanyan Liu
Observational
200
Zhengzhou
2026-07
Not yet open
Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS
NCT07687667Polycystic Ovary Syndrome (PCOS), Obesity, Infertility, Female
DrugMetformin
Peking University Third Hospital
Not applicable
406
Beijing
2026-07
Not yet open
Sun Yat-sen University
Phase 2
144
Guangzhou
2026-07
Not yet open
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
NCT07676266Multiple Sclerosis (MS), Myasthenia Gravis (MG), Neuromyelitis Optica Spectrum Disorder, Systemic Lupus Erythematosus
The Affiliated Hospital of Qingdao University
Phase 1
18
Qingdao
2026-07
Not yet open
Peking University Third Hospital
Not applicable
240
Karamay
2026-07
Not yet open
Bone Cancer Surgery Prospective Database
NCT07669103Bone Cancer Surgery
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
400
Hangzhou
2026-07
Not yet open
The Third Affiliated hospital of Zhejiang Chinese Medical University
Not applicable
126
Hangzhou
2026-07
Not yet open
Huashan Hospital
Phase 2
60
Shanghai
2026-07
Not yet open
A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms
NCT07715994Extrapyramidal Symptoms, Drug-induced Parkinsonism, Akathisia, Drug-Induced, Tardive Dyskinesia (TD)
Shanghai Mental Health Center
Observational
180
Shanghai
2026-07
Not yet open
Chongqing Normal University
Not applicable
60
Chongqing
2026-07
Not yet open
Chengdu Suncadia Medicine Co., Ltd.
Phase 2
190
Shanghai, Hangzhou
2026-07
Not yet open
Shanghai RAAS Blood Products Co., Ltd.
Phase 2
12
Tianjin
2026-07
Not yet open
Lian Yang
Observational
100,000
Wuhan
2026-07
Not yet open
HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion
NCT07699757Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma (mPDAC), Advanced Solid Tumors
DrugsHSK41959·Cisplatin/Carboplatin·Sintilimab·Nab-paclitaxel
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
258
Shanghai
2026-07
Not yet open
Shandong Suncadia Medicine Co., Ltd.
Phase 3
3,690
Tianjin, Hangzhou
2026-07
Not yet open
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
127
Beijing, Lanzhou, Guangzhou, Anyang, Luoyang, Zhengzhou, Nanjing, Xuzhou
2026-07
Not yet open
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 1
84
Hangzhou
2026-07
Not yet open
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 1
100
Qingdao
2026-07
Not yet open
Zhifeng Zhao, PhD
Phase 2
46
Xi'an
2026-07
Not yet open
Guangdong Provincial People's Hospital
Observational
3,000
Chongqing, Guangzhou, Xuzhou, Hangzhou
2026-07
Recruiting
Zhejiang Cancer Hospital
Not applicable
30
Hangzhou
2026-07
Not yet open
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3
240
Zhengzhou
2026-07
Not yet open
Effects of Functional Oils on Obesity With Mild Cognitive Impairment
NCT07690384Obesity, Mild Cognitive Impairment
Capital Medical University
Not applicable
100
Beijing
2026-07
Not yet open
A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis
NCT07709910Participants With Obesity and Knee Osteoarthritis
DrugRibupatide
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 3
382
Shanghai
2026-07
Not yet open
Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)
NCT07654062Prediabetes, Impaired Fasting Glucose, Impaired Glucose Tolerance (Prediabetes)
DrugMazdutide
Shandong Provincial Hospital
Phase 4
150
Jinan
2026-07
Recruiting
Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)
NCT07719140Childhood-onset Systemic Lupus Erythematosus, Lupus Nephritis (LN)
DrugPrednisone
Peking Union Medical College Hospital
Phase 4
198
Beijing, Chongqing, Shenzhen, Changsha, Nanjing, Changchun, Shanghai
2026-07
Not yet open
Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet
NCT07696091Non-cystic Fibrosis Bronchiectasis、Chronic Sinusitis Without Nasal Polyps、Chronic Obstructive Pulmonary Disease
DrugsRSS0343·Clarithromycin·Rifampicin
Reistone Biopharma Company Limited
Phase 1
40
Guangzhou
2026-07
Not yet open
Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors
NCT07624214Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumors
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
Phase 1
198
Hangzhou
2026-07
By invitation
Compassionate Administration of ZVS101e for Extended Treatment
NCT07307469Bietti Crystalline Corneoretinal Dystrophy
DrugZVS101e
Chigenovo Co., Ltd
Not applicable
32
Beijing, Guangzhou, Zhengzhou, Chengdu, Tianjin
2026-07
Not yet open
Ruijin Hospital
Phase 1/2
108
Shanghai
2026-07
Not yet open
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
404
Beijing, Kunming
2026-07
Not yet open
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Phase 1/2
264
Shanghai
2026-07
Not yet open
Ruijin Hospital
Phase 3
652
Shanghai
2026-07
Not yet open
Tianjin Medical University Cancer Institute and Hospital
Not applicable
96
Tianjin
2026-07
Not yet open
Peking University
Not applicable
480
Wuhu, Zhengzhou, Shenyang, Zibo, Shanghai, Hangzhou, Jinhua, Beijing
2026-07
Not yet open
Fudan University
Phase 2
36
Shanghai
2026-07
Not yet open
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
252
Shanghai
2026-07
Not yet open
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
120
Shanghai
2026-07
Not yet open
Second Xiangya Hospital of Central South University
Not applicable
105
Changsha
2026-07
Not yet open
Nanjing First Hospital, Nanjing Medical University
Phase 3
106
Nanjing
2026-07
Not yet open
Different Pressure Tissue Flossing Combined With Exercise for Chronic Ankle Instability
NCT07667816Chronic Ankle Instability, Ankle Instability
Chengdu Sport University
Not applicable
48
Chengdu
2026-07
Not yet open
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
35
Nanjing
2026-07
Not yet open
Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia
NCT07714070Endometrial Neoplasms, Endometrial Cancer, Atypical Endometrial Hyperplasia, Progestin Resistance
DrugsOrlistat·Progestin
Peking University People's Hospital
Phase 2
48
Beijing
2026-07
Not yet open
A Phase 2 Study of HW211026
NCT07513454Actinic Keratosis
DrugHW211026
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Phase 2
80
Shanghai
2026-07
Not yet open
Beijing Geekgene Technology Co., LTD
Early Phase 1
10
Beijing
2026-07
Not yet open
Shanghai 10th People's Hospital
Not applicable
396
Shanghai
2026-07
Not yet open
The First Affiliated Hospital of Air Force Medical University
Phase 1/2
162
Xi’an
2026-07
Not yet open
Xiangya Hospital of Central South University
Observational
120
Changsha
2026-07
Not yet open
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases
NCT07674147Autoimmune Diseases, SLE - Systemic Lupus Erythematosus, SSc-Systemic Sclerosis, IIM- Idiopathic Inflammatory Myopathies
The Children's Hospital of Zhejiang University School of Medicine
Early Phase 1
30
Nanjing, Hangzhou
2026-07
Not yet open
Tongji Hospital
Not applicable
146
Wuhan
2026-06-30
Recruiting
AbbVie
Phase 2/3
660
2026-06-30
Not yet open
Sichuan University
Observational
200
Chengdu
2026-06-30
Not yet open
Ming Zhong
Observational
40
Shanghai
2026-06-30
Recruiting
Shanghai Henlius Biotech
Phase 1
72
Guangzhou, Hongkou, Taiyuan
2026-06-30
Not yet open
Sichuan University
Observational
500
Chengdu
2026-06-30
Not yet open
Serplulimab Plus Decitabine and CAPOX Before Surgery for Locally Advanced Colorectal Cancer
NCT07691632Locally Advanced Colorectal Cancer, Colorectal Adenocarcinoma
DrugsDecitabine·Serplulimab·Capecitabine
Tianjin Medical University Cancer Institute and Hospital
Phase 2
35
Tianjin
2026-06-30
Not yet open
Henan Cancer Hospital
Phase 2
45
Zhengzhou
2026-06-30
Not yet open
Sichuan University
Phase 1
21
Chengdu
2026-06-30
Not yet open
Tianjin Medical University Cancer Institute and Hospital
Phase 2
120
Tianjin
2026-06-30
Active, closed
Boehringer Ingelheim
Phase 2
344
Huzhou, Jinan, Luoyang, Nanjing, Ningbo, Qinhuangdao, Tianjin, Yichang
2026-06-30
Recruiting
Climb Bio, Inc.
Phase 1/2
30
Mianyang, Baoji, Beijing, Bengbu, Changsha, Hefei, Nanchang, Suzhou
2026-06-30
Recruiting
Lefamulin Post-Market Surveillance Study
NCT07697885Community-Acquired Pneumonia (CAP)
Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
Observational
1,000
Beijing
2026-06-30
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
29
Beijing
2026-06-30
Recruiting
Chengdu Suncadia Medicine Co., Ltd.
Phase 1
180
Chengdu
2026-06-30
By invitation
Immunity in Critical Sepsis
NCT07770347Sepsis
Beijing Chao Yang Hospital
Not applicable
2,400
Beijing
2026-06-30
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
24
Nanjing
2026-06-30
Recruiting
A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH
NCT07581951MASH - Metabolic Dysfunction-Associated Steatohepatitis, NASH (Non-Alcoholic Steatohepatitis)
Haisco Pharmaceutical Group Co., Ltd.
Phase 3
886
Beijing
2026-06-30
Not yet open
Beijing GoBroad Hospital
Phase 2
40
Beijing
2026-06-30
Not yet open
GoFast CAR T-Cell Therapy for Recurrent Refractory B-Cell Lymphoma
NCT07670260Relapsed or Refractory Large B-cell Lymphoma
Chinese PLA General Hospital
Early Phase 1
9
Beijing
2026-06-30
By invitation
Beijing Chao Yang Hospital
Observational
2,400
Beijing
2026-06-30
Not yet open
The Third Peoples Hospital of Dalian
Phase 4
186
Dalian
2026-06-30
Not yet open
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
30
Shanghai
2026-06-30
Recruiting
Peking University Third Hospital
Observational
114
Beijing, Cangzhou, Chengdu
2026-06-30
Not yet open
Sun Yat-sen University
Not applicable
84
Gu'ang'zhou
2026-06-30
Recruiting
Zhejiang University
Phase 2
25
Hangzhou
2026-06-30
Recruiting
Beijing Municipal Administration of Hospitals
Observational
40
Beijing
2026-06-30
Not yet open
Shanghai Jiao Tong University School of Medicine
Phase 1/2
112
Xuzhou
2026-06-30
Recruiting
HighField Biopharmaceuticals Corporation
Phase 2
30
Shanghai
2026-06-30
Not yet open
Jing Liu
Not applicable
260
Beijing
2026-06-30
Not yet open
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
80
Beijing
2026-06-30
Not yet open
BOE Technology Group Co., Ltd.
Phase 1
35
Beijing
2026-06-30
Not yet open
Huazhong University of Science and Technology
Not applicable
208
Wuhan
2026-06-30
Active, closed
Fudan University
Observational
40
Shanghai
2026-06-30
Recruiting
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Not applicable
74
Shanghai
2026-06-30
Recruiting
Cold-Region Exposure and Cardiac Remodeling After PCI
NCT07773870Coronary Artery Disease, Percutaneous Coronary Intervention (PCI), Left Ventricular Remodeling, Cold Exposure
Chinese PLA General Hospital
Observational
400
Beijing
2026-06-30
Not yet open
Beijing Tongren Hospital
Phase 4
159
Beijing, Guangzhou, Shanghai, Xi'an, Zhongshan
2026-06-30
Not yet open
Fudan University
Phase 1/2
138
Shanghai
2026-06-30
Not yet open
A Clinical Study of ZL-85FA Tablets
NCT07339748Advanced Solid Tumor
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 1/2
51
Hefei
2026-06-30
Not yet open
Ruijin Hospital
Phase 2
112
Shanghai
2026-06-30
Recruiting
Hrain Biotechnology Co., Ltd.
Phase 1
18
Shanghai
2026-06-30
Recruiting
Institute of Hematology & Blood Diseases Hospital, China
Phase 1/2
32
Tianjin
2026-06-30
Recruiting
Pfizer
Phase 2
120
Beijing, Guangzhou, Jinan, Shanghai
2026-06-30
Not yet open
A Real-world HCM-cohort Trial
NCT07638033Hypertrophic Cardiomyopathy (HCM)
Xijing Hospital
Observational
3,000
Xi'an
2026-06-30
Recruiting
Exploration of Whole-Brain Radiotherapy Combined With PD-1 Inhibitors on Brain Injury
NCT07905937Small Cell Lung Cancer ( SCLC ), Brain Injury
Guizhou Medical University
Observational
42
Guiyang
2026-06-30
Not yet open
Fujian Cancer Hospital
Phase 2
35
Fuzhou, Quanzhou
2026-06-30
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
66
Shenyang
2026-06-30
Recruiting
West China Hospital
Phase 2
9
Chengdu
2026-06-29
Recruiting
Bambusa Therapeutics
Phase 1/2
48
Wuhu, Beijing, Guangzhou, Shijiazhuang, Jinzhou, Wuxi, Taiyuan, Xi’an
2026-06-29
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
538
Beijing
2026-06-29
Recruiting
Zhongnan Hospital
Not applicable
18
Wuhan
2026-06-29
Recruiting
AMT-116 in Combination With AK112 in Patients With Lung Cancer
NCT07590531Advanced Non-small Cell Lung Cancer (NSCLC)
DrugsAMT-116·Ivonescimab
Multitude Therapeutics Inc.
Phase 1/2
118
Guangzhou, Hangzhou
2026-06-29
Recruiting
BrightGene Bio-Medical Technology Co., Ltd.
Phase 2
200
Beijing
2026-06-29
Recruiting
AstraZeneca
Phase 3
4,500
Binzhou, Chengdu, Deyang, Ganzhou, Guangzhou, Haikou, Hangzhou, Huaian
2026-06-29
Recruiting
Mindfulness Intervention for Emotional Distress (MIED) in Patients With GERD
NCT07667894Gastroesophageal Reflux Disease, Emotional Distress
Xinghua Liu
Not applicable
500
Beijing, Baiyin, Shenzhen, Guiyang, Xingtai, Xinle, Chifeng, Hohhot
2026-06-29
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 2
74
Shanghai
2026-06-29
Recruiting
Ruijin Hospital
Not applicable
22
Shanghai
2026-06-28
By invitation
Capital Medical University
Observational
868
Beijing
2026-06-28
Not yet open
Sinovac Life Sciences Co., Ltd.
Phase 3
600
Fuyang, Hefei, Beijing, Guangzhou, Shenzhen, Liuzhou, Zunyi, Shijiazhuang
2026-06-28
By invitation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Early Phase 1
18
Wuhan
2026-06-28
Active, closed
Guizhou Provincial People's Hospital
Observational
52
Guiyang
2026-06-27
Recruiting
Shiyou Wei
Phase 4
62
Tianmen
2026-06-27
Recruiting
Suzhou Abogen Biosciences Co., Ltd.
Phase 3
18,000
Jinan, Nanning, Shijiazhuang, Zhejiang
2026-06-27
Not yet open
ScinnoHub Pharmaceutical Co., Ltd.
Phase 1
240
Shanghai
2026-06-26
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
40
Guangzhou
2026-06-26
Recruiting
Chiesi Farmaceutici S.p.A.
Phase 3
554
Beijing
2026-06-26
Recruiting
Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
NCT07724756Pediatric Malignant Solid Tumor, Febrile Neutropenia (FN), Neutropenia
Qilu Pharmaceutical Co., Ltd.
Phase 2
18
Beijing
2026-06-26
Recruiting
Genmab
Phase 3
82
Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Jinan
2026-06-26
Not yet open
Shanghai Helioson Pharmaceutical Co., Ltd.
Phase 1/2
114
Guangzhou
2026-06-26
Recruiting
Allogeneic WTX-212C in Advanced Solid Tumors
NCT07556653Advanced Solid Tumors
Zhejiang Provincial People's Hospital
Early Phase 1
24
Hangzhou
2026-06-26
Not yet open
General Hospital of Ningxia Medical University
Not applicable
96
Yinchuan
2026-06-25
Recruiting
Shenyang Northern Hospital
Phase 4
110
Shenyang
2026-06-25
Recruiting
Construction of a Prospective Cohort Database for the Perioperative Period of Cardiac Surgery
NCT07662317Valve Heart Disease, Coronary Artery Disease, Coronary Heart Disease, Aortic Diseases
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
10,000
Hangzhou
2026-06-25
Recruiting
Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease
NCT07685873Parkinson Disease, Parkinson Disease Dementia, Parkinson's Disease and Parkinsonism
Tianjin Medical University
Observational
200
Hefei, Qingdao, Tianjin
2026-06-25
Recruiting
Jecho Biopharmaceuticals Co., Ltd.
Phase 1
14
Beijing
2026-06-25
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Phase 4
78
Guangzhou, Suqian, Shanghai, Hangzhou, Lishui
2026-06-25
Active, closed
Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd.
Phase 1
12
Guangzhou
2026-06-25
Recruiting
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 1
42
Guangzhou, Shanghai
2026-06-25
Recruiting
Monoamine Oxidase A PET/CT in Various MAO-A-Related Disease
NCT07685860Depression, Anxiety, Heart Injuries
Tianjin Medical University
Observational
200
Hefei, Qingdao, Tianjin
2026-06-25
Recruiting
GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders
NCT07660939Plasma Cell Disorders, Multiple Myeloma (MM)
Peking University First Hospital
Phase 1
50
Beijing
2026-06-25
Recruiting
Efgartigimod in Anti-NMDA Receptor Encephalitis.
NCT07822776Encephalitis Autoimmune
Beijing Tongren Hospital
Phase 2
20
Beijing
2026-06-25
Recruiting
Clinical Study of Coronary Extension Catheter
NCT07742345Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI)
BrosMed Medical Co., Ltd
Not applicable
69
Beijing
2026-06-25
Not yet open
Beijing Tiantan Hospital
Phase 4
12
Beijing
2026-06-24
Recruiting
Nodal-Region Sparing Short-Course RT With Chemo-PD-1/Bevacizumab vs. Short-Course RT With Chemotherapy as TNT in pMMR/MSS Locally Advanced Rectal Cancer
NCT07674732Short-course Radiotherapy Plus Chemotherapy, Nodal-Region Sparing Short-Course Radiotherapy Followed by Sequential Chemotherapy With PD-1 Monoclonal Antibody and Bevacizumab
Dechang Diao
Phase 2
76
Guangzhou
2026-06-24
Recruiting
TIS for Improving Cognitive Impairment in Schizophrenia
NCT07647380Schizophrenia Disorder, Cognitive Impairments
Central South University
Not applicable
50
Changsha
2026-06-24
Recruiting
Study of AHB-171 in Chronic Hepatitis B Participants
NCT07630727Hepatitis B, Chronic (CHB)
DrugAHB-171
Ausper Biopharma Co., Ltd.
Phase 2
138
Beijing, Chongqing, Xiamen, Guangzhou, Nanning, Zhengzhou, Changzhou, Jilin City
2026-06-24
Recruiting
AstraZeneca
Phase 2
84
Anyang, Beijing, Changsha, Chengdu, Chizhou, Haikou, Hefei, Hohhot
2026-06-24
Recruiting
RenJi Hospital
Not applicable
140
Shanghai
2026-06-24
Recruiting
Peking University Cancer Hospital & Institute
Phase 1/2
30
Beijing
2026-06-24
Recruiting
Research on Colorectal Cancer Recurrence Monitoring and Individualized Treatment Based on MRD
NCT07775950Colorectal Cancer (MSI-H), Molecular Residual Disease
Sun Yat-sen University
Not applicable
100
Guangzhou
2026-06-23
Not yet open
General Hospital of Ningxia Medical University
Not applicable
208
Yinchuan
2026-06-23
Recruiting
Shanghai Minwei Biotechnology Co., Ltd
Phase 2
240
Beijing
2026-06-23
Recruiting
Tianjin First Central Hospital
Phase 2
50
Tianjin
2026-06-23
Recruiting
OHB Pediatrics Ltd.
Phase 3
165
2026-06-23
Recruiting
Hoffmann-La Roche
Phase 3
380
Guangzhou, Nanjing, Qingdao, Tianjin, Kunming, Hangzhou, Jinan, Nanning
2026-06-23
Recruiting
Nanfang Hospital, Southern Medical University
Phase 4
288
Guangzhou
2026-06-23
Recruiting
BeOne Medicines
Phase 1
118
Lanzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Suzhou, Nanchang, Tianjin
2026-06-23
Not yet open
Second Affiliated Hospital of Guangzhou Medical University
Phase 2
20
Guangzhou
2026-06-22
Recruiting
AstraZeneca
Observational
2,000
Beijing, Chengdu, Fuzhou, Guangzhou, Nanchang, Shanghai, Shenyang, Shijiazhuang
2026-06-22
By invitation
The First Affiliated Hospital of Air Force Medical University
Observational
1,000
Xi’an
2026-06-22
Recruiting
Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion
NCT07552610Acute Ischemic Stroke, Large Vessel Occlusion, Thrombectomy, Neutrophil Extracellular Trap Formation
DrugSivelestat sodium
Xuanwu Hospital, Beijing
Not applicable
868
Weifang, Beijing
2026-06-22
Not yet open
Fujian Provincial Hospital
Phase 4
900
Fuzhou
2026-06-22
Recruiting
Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma
NCT07314216NSCLC (Non-small Cell Lung Carcinoma), Stage III, EGFR Uncommon Mutations
DrugFurmonertinib
Hunan Cancer Hospital
Phase 2
15
Changsha
2026-06-22
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
960
Beijing, Shanghai
2026-06-22
Recruiting
Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP
NCT07380113Pruritus Chronic, Kidney Diseases, Chronic, Renal Insufficiency, Chronic, Uremia; Chronic
DrugAnrikefon
Zhujiang Hospital
Phase 4
50
Guangzhou
2026-06-22
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
198
Bengbu, Bozhou, Beijing, Chongqing, Lanzhou, Guangzhou, Jiangmen, Shenzhen
2026-06-22
Recruiting
GenSci144 Tablets Phase I Clinical Trial
NCT07685210Phenylketonuria
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
48
Jinan
2026-06-22
Recruiting
Hangzhou Yirui Pharmaceutical Technology Co., Ltd
Phase 1
18
Langfang
2026-06-22
Not yet open
Nanfang Hospital, Southern Medical University
Phase 2
88
Guangzhou
2026-06-22
Recruiting
HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)
NCT07379190Stroke, Acute, Stroke, Ischemic, Cerebral Infarction
DrugsTirofiban·Clopidogrel·Aspirin
Weifang Medical University
Phase 3
458
Weifang
2026-06-22
Recruiting
TCRx Therapeutics Co.Ltd
Observational
200
Bengbu, Hefei
2026-06-22
Not yet open
Akeso
Phase 2
132
Shanghai
2026-06-22
Recruiting
Institute of Hematology & Blood Diseases Hospital, China
Phase 4
38
Tianjin
2026-06-22
Recruiting
Metabolic and Functional Study of γδ T Cells in Critically Ill Patients
NCT07680816Sepsis, Critical Illness, Immunosuppression, MODS
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
105
Wuhan
2026-06-21
Recruiting
Oral Lactulose for Gastrointestinal Recovery After Complex Appendectomy
NCT07589465Ileus Postoperative, Gastrointestinal Function, Complicated Appendicitis
DrugLactulose
Nanchong Central Hospital
Not applicable
150
Sichuan
2026-06-21
Recruiting
Nanchong Central Hospital
Not applicable
140
Nanchong
2026-06-21
Recruiting
Xidian University
Not applicable
25
Xi'an
2026-06-21
Recruiting
Shanghai Zhongshan Hospital
Not applicable
100
Shanghai
2026-06-20
Not yet open
Shandong Provincial Hospital
Not applicable
106
Jinan
2026-06-20
Not yet open
The Affiliated Hospital of Putian University
Not applicable
124
Putian
2026-06-20
Recruiting
The First Affiliated Hospital of Zhengzhou University
Not applicable
339
Anyang, Jiaozuo, Kaifeng, Luohe, Luoyang, Nanyang, Sanmenxia, Shangqiu
2026-06-20
Recruiting
University of Electronic Science and Technology of China
Not applicable
80
Chengdu
2026-06-20
Recruiting
Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma
NCT07648823Recurrent Glioblastoma (WHO-Grade IV Glioma), Recurrent Glioblastoma, Glioblastoma (GBM), Recurrent Glioblastoma IDH Wildtype
Beijing Tiantan Hospital
Early Phase 1
5
Beijing
2026-06-20
Recruiting
China National Center for Cardiovascular Diseases
Not applicable
200
Beijing
2026-06-20
Not yet open
Sichuan University
Phase 1
9
Chengdu
2026-06-20
Not yet open
West China Hospital
Observational
150
Chengdu
2026-06-20
Recruiting
University of Electronic Science and Technology of China
Not applicable
80
Chengdu
2026-06-20
By invitation
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
400
Hangzhou
2026-06-20
Not yet open
Qilu Hospital of Shandong University
Not applicable
70
Jinan
2026-06-20
Recruiting
University of Electronic Science and Technology of China
Not applicable
80
Chengdu
2026-06-20
Active, closed
First Affiliated Hospital, Sun Yat-Sen University
Phase 2
20
Guangzhou
2026-06-20
Recruiting
University of Electronic Science and Technology of China
Not applicable
80
Chengdu
2026-06-20
Recruiting
Multi-Agent Collaborative ADR Prediction With Human-Machine Decision Comparison
NCT07808866Adverse Drug Reactions, Clinical Decision Support
Peking University Third Hospital
Observational
20,000
Beijing
2026-06-19
Recruiting
West China Second University Hospital
Not applicable
62
Hefei, Nanning, Guiyang, Zunyi, Nanchang, Xi'an, Chengdu, Ürümqi
2026-06-19
Recruiting
Chendu DIAO Pharmaceutical Group CO., LTD.
Phase 3
840
Beijing
2026-06-19
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
51
Hefei, Fuzhou, Guangzhou, Nanning, Cangzhou, Chengde, Shijiazhuang, Xingtai
2026-06-18
By invitation
Tang-Du Hospital
Observational
200
Beijing, Chongqing, Shenzhen, Wuhan, Nanjing, Shengyang, Qingdao, Xi’an
2026-06-18
Recruiting
Liaoning Cancer Hospital & Institute
Not applicable
54
Shenyang
2026-06-18
Not yet open
ScinnoHub Pharmaceutical Co., Ltd.
Phase 2
30
Foshan, Guangzhou, Maoming, Liuzhou, Nanning, Haikou, Chengdu
2026-06-18
Not yet open
EBV mRNA Vaccine for the Prevention of EBV-Related Diseases After Allo-HSCT
NCT07674199Patients After Hematopoietic Stem Cell Transplantation
DrugEBV mRNA vaccine
The General Hospital of Western Theater Command
Early Phase 1
20
Chengdu
2026-06-18
Recruiting
Moon (Guangzhou) Biotechnology Co., Ltd.
Not applicable
200
Guangzhou
2026-06-18
Recruiting
CW-301 FIH Study of CAN016
NCT07664150Patients With Advanced Solid Tumors
Canwell Biotech Limited
Phase 1/2
90
Beijing
2026-06-18
Recruiting
First Affiliated Hospital of Wannan Medical College
Phase 2
200
Wuhu
2026-06-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
310
Hefei, Beijing, Xiamen, Guangzhou, Guilin, Nanning, Shijiazhuang, Wuhan
2026-06-18
Not yet open
One-Click Autofocus Versus Segmented Focus in Gastric Endoscopy
NCT07664813Stomach Neoplasms, Stomach Diseases
Shandong University
Not applicable
93
Jinan
2026-06-18
Recruiting
EnnovaBio
Phase 1
56
Shanghai
2026-06-17
Recruiting
Sun Yat-sen University
Phase 2
42
Guangzhou
2026-06-17
Not yet open
Evaluation of the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of BBM-C101 Injection in Patients With Cervical High-Grade Squamous Intraepithelial Lesion(HSIL)
NCT07668960High-grade Squamous Intraepithelial Lesions of the Cervix Associated With Human Papillomavirus (HPV) Type 16 and/or HPV Type 18 Infection
Shanghai Mianyi Biopharmaceutical Co., Ltd.
Phase 1/2
60
Beijing, Chongqing, Zhangzhou, Jinan
2026-06-17
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
200
Hangzhou
2026-06-17
Recruiting
The United Bio-Technology (Hengqin) Co., Ltd.
Phase 1
53
Hefei
2026-06-17
Active, closed
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 3
106
Jinan
2026-06-17
Recruiting
Jecho Biopharmaceuticals Co., Ltd.
Phase 1/2
40
Shanghai
2026-06-17
Recruiting
Vantive Health LLC
Observational
750
Beijing, Chongqing, Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Changsha
2026-06-17
Recruiting
Shandong Cancer Hospital and Institute
Early Phase 1
7
Jinan
2026-06-17
Recruiting
CSL Behring
Phase 1
24
Beijing
2026-06-17
Recruiting
Risk Factor Assessment for Acute Pulmonary Hypertension Crisis
NCT07653958Pulmonary Hypertension, Pulmonary Hypertension Crisis
Peking Union Medical College Hospital
Observational
5,000
Guangzhou, Kunming, Beijing, Shanghai
2026-06-17
Recruiting
First Affiliated Hospital of Wenzhou Medical University
Observational
4,600
Wenzhou
2026-06-17
Recruiting
Henan Cancer Hospital
Phase 3
1,044
Zhengzhou
2026-06-16
Recruiting
Rong Tao
Phase 2
69
Shanghai
2026-06-16
Not yet open
Shanghai Best-Link Bioscience, LLC
Phase 1
33
Harbin, Zhengzhou, Wuhan, Changzhou, Shenyang, Taizhou, Shanghai
2026-06-16
Not yet open
Ou Bai, MD/PHD
Phase 2
66
Changchun
2026-06-16
Recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
102
Shanghai
2026-06-16
Recruiting
Nanjing Immunophage Biotech Co., Ltd
Phase 1/2
52
Shanghai
2026-06-16
Recruiting
General Hospital of Ningxia Medical University
Observational
80
Yinchuan
2026-06-16
Recruiting
Full-Course ECMO Strategy for Moderate-to-Severe ARDS
NCT07726953Acute Respiratory Distress Syndrome
Southeast University, China
Not applicable
500
Beijing, Changchun, Chengdu, Chenzhou, Dalian, Fuzhou, Guangzhou, Hangzhou
2026-06-16
By invitation
Thiotepa + TBI + Fludarabine + Etoposide for Allo-HSCT in Patients With R/R or High-risk Acute Leukemia
NCT07920796Acute Leukemia, High Risk, Acute Leukemia Refractory, Acute Leukemia, Relapsed
DrugsThiotepa·Etoposide·Fludarabine
Guangdong Second Provincial General Hospital
Phase 2
50
Guangzhou
2026-06-16
Active, closed
Chinese SLE Treatment And Research Group
Phase 4
15
Beijing
2026-06-16
Recruiting
Fujian Cancer Hospital
Phase 2
25
Fuzhou
2026-06-16
By invitation
First Affiliated Hospital of Zhejiang University
Not applicable
30
Hangzhou
2026-06-16
Recruiting
Xidian University
Not applicable
30
Xi'an
2026-06-16
Recruiting
Xidian University
Not applicable
30
Xi'an
2026-06-16
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
15
Hangzhou
2026-06-16
Recruiting
Tianjin First Central Hospital
Not applicable
132
Tianjin
2026-06-16
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
92
Beijing
2026-06-16
Recruiting
Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS
NCT07726940Acute Respiratory Distress Syndrome (ARDS)
Southeast University, China
Observational
1,776
Beijing, Fuzhou, Nanjing, Jinan, Chengdu, Hangzhou, Changchun, Chenzhou
2026-06-16
Recruiting
VitsGen Therapeutics Inc.
Phase 1
10
Shanghai
2026-06-16
Recruiting
Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP
NCT07656909Kaposiform Hemangioendothelioma (KHE), Kasabach Merritt Phenomenon
DrugsRapamycin·Sirolimus
Yi Ji
Phase 2/3
76
Chengdu
2026-06-16
Recruiting
Jinling Hospital, China
Phase 2
75
Nanjing, Wuxi
2026-06-16
Recruiting
SGRT in Head and Neck Cancer Radiotherapy
NCT07726407Head and Neck Cancer, Radiotherapy, Conformal (IMRT)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
40
Guangzhou
2026-06-15
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
562
Zhengzhou, Shanghai
2026-06-15
Recruiting
Xijing Hospital
Not applicable
10,000
Zhaoqing, Jinan, Mianyang, Wuwei, Wuxi
2026-06-15
Recruiting
Cheng Qi
Phase 4
50
Wuhan
2026-06-15
Recruiting
Huazhong University of Science and Technology
Phase 4
180
Wuhan
2026-06-15
Not yet open
Danatlas Pharmaceuticals Co., Ltd
Phase 2
30
Guangzhou, Beijing
2026-06-15
Not yet open
Nanjing Medical University
Not applicable
40
Nanjing
2026-06-15
Recruiting
CLE vs. ROSE for Ex Vivo Lung Biopsy Assessment
NCT07725510Peripheral Pulmonary Lesions (PPLs)
Guangzhou Medical University
Observational
30
Guangzhou
2026-06-15
Not yet open
Jinling Hospital, China
Phase 4
174
Nanjing
2026-06-15
Not yet open
Stellate Ganglion Block and Prognosis of Neurological Function After Subarachnoid Hemorrhage
NCT07652749Aneurysmal Subarachnoid Hemorrhage, Stellate Ganglion Block, Neurological Prognosis
Beijing Tiantan Hospital
Not applicable
560
Beijing
2026-06-15
Not yet open
Zhengli Di
Not applicable
30
Xi'an
2026-06-15
Not yet open
Dan Bing
Not applicable
180
Wuhan
2026-06-15
Not yet open
Ruijin Hospital
Phase 1/2
40
Shanghai
2026-06-15
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Phase 2
56
Tianjin
2026-06-15
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
649
Beijing
2026-06-15
Recruiting
Hidden Hearing Loss in Older Adults
NCT07646119Hidden Hearing Loss
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
200
Shanghai
2026-06-15
Not yet open
Chinese University of Hong Kong
Phase 2
200
Hefei, Wenzhou
2026-06-15
Recruiting
Remimazolam Versus Midazolam for General Anesthesia Induction in Elderly Patients Undergoing Non-Cardiac Surgery
NCT07746505General Anesthesia, Aged, Intraoperative Hypotension, Anxiety
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
1,000
Hangzhou
2026-06-15
Not yet open
Eastern Hepatobiliary Surgery Hospital
Phase 2
123
Shanghai
2026-06-15
Not yet open
Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies
NCT07636486Luspatercept, Epoetin, Poor Erythroid Engraftment, Hematological Malignancies
DrugLuspatercept
Nanfang Hospital, Southern Medical University
Phase 2/3
90
Guangzhou
2026-06-15
Recruiting
yilong Wang
Early Phase 1
60
Beijing
2026-06-15
Not yet open
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
249
Shenzhen, Nanjing
2026-06-15
Recruiting
Merz North America, Inc.
Not applicable
218
Beijing, Guangzhou, Nanjing, Xi'an, Shanghai
2026-06-15
Recruiting
Moon (Guangzhou) Biotechnology Co., Ltd.
Not applicable
60
Guangzhou
2026-06-15
Recruiting
Shanghai Changzheng Hospital
Phase 2
20
Shanghai
2026-06-15
Not yet open
CS-121 APOC3 Base Editing in Severe Hypertriglyceridemia
NCT07657780Severe Hypertriglyceridemia (sHTG)
DrugCS-121
CorrectSequence Therapeutics Co., Ltd
Early Phase 1
15
Hefei
2026-06-15
Not yet open
Tang-Du Hospital
Not applicable
60
Xi'an
2026-06-15
Recruiting
Beijing 302 Hospital
Phase 2
21
Beijing, Guangzhou, Shenzhen
2026-06-15
Not yet open
Jiangsu Cancer Institute & Hospital
Phase 2
80
Changzhou, Huai'an, Lianyungang, Nanjing, Nantong, Suzhou, Wuxi, Xuzhou
2026-06-15
Recruiting
Peking Union Medical College Hospital
Observational
100
Beijing
2026-06-15
Recruiting
Outcomes for Robotics in Orthopaedic Trauma
NCT07732803Orthopaedic Trauma
Prince of Wales Hospital, Shatin, Hong Kong
Not applicable
200
Hong Kong
2026-06-15
Not yet open
Lingyi Biotech Co., Ltd.
Phase 1/2
18
Hangzhou
2026-06-15
Not yet open
Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers
NCT07656740Gastrointestinal Cancer, Colorectal (Colon or Rectal) Cancer, Stomach (Gastric) Cancer
Peking University Cancer Hospital & Institute
Observational
50
Beijing
2026-06-15
Recruiting
Peking University People's Hospital
Not applicable
180
Beijing
2026-06-15
Not yet open
Changhai Hospital
Not applicable
2,689
Shanghai
2026-06-15
Recruiting
Peking University Third Hospital
Not applicable
80
Beijing
2026-06-15
Recruiting
A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC
NCT07562581Non-small Cell Lung Caner, KRAS-mutated, Metastasis, Previous Treamted
DrugsLuvometinib·Anlotinib
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 2
48
Shanghai
2026-06-15
Not yet open
Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial
NCT07699770Neuromyelitis Optica Spectrum Disorders (NMOSD), Neuropathic Pain
DrugCrisugabalin
Tang-Du Hospital
Phase 4
110
Beijing, Chongqing, Harbin, Hohhot, Changchun, Shenyang, Xi'an, Ürümqi
2026-06-15
Recruiting
Synusight Biotech (Shanghai) Co., Ltd.
Phase 1
30
Wuxi, Shanghai
2026-06-15
Recruiting
Shenzhen Third People's Hospital
Phase 2
96
Shenzhen
2026-06-15
Not yet open
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
210
Beijing
2026-06-15
Recruiting
Hansoh BioMedical R&D Company
Phase 1
396
Guangzhou
2026-06-15
Active, closed
Shanghai Zhongshan Hospital
Observational
60,000
Shanghai
2026-06-15
Recruiting
Clinical Study of CFH Protein Via Ice Microneedles for Radiation-Induced Skin Fibrosis
NCT07567235Radiation-Induced Skin Fibrosis, Head and Neck Squamous Cell Carcinoma
West China Hospital
Phase 1
9
Chengdu
2026-06-15
Recruiting
Hefei Xinzhu Biological Technology Co., Ltd.
Phase 1/2
114
Changsha, Shanghai, Zhengzhou
2026-06-15
Recruiting
China Medical University, China
Not applicable
60
Shenyang
2026-06-15
Not yet open
Taizhou Second People's Hospital
Observational
200
Taizhou
2026-06-15
Recruiting
Sir Run Run Shaw Hospital
Not applicable
190
Binzhou, Hangzhou
2026-06-14
Not yet open
Second Hospital of Shanxi Medical University
Not applicable
176
Taiyuan
2026-06-13
Recruiting
Shandong Suncadia Medicine Co., Ltd.
Phase 1
66
Shanghai
2026-06-12
Recruiting
Hangzhou PhecdaMed Co., Ltd.
Phase 2
204
Hangzhou
2026-06-12
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
27
Hangzhou
2026-06-12
Recruiting
A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.
NCT07606937Relapsed/Refractory Large B-cell Lymphoma
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Early Phase 1
12
Beijing, Guangzhou, Suzhou, Shanghai, Chengdu, Tianjin
2026-06-12
Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1
16
Wuhan
2026-06-12
Not yet open
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
50
Shanghai
2026-06-12
Active, closed
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3
60
Tianjin, Fuyang, Fuzhou, Guangzhou, Hefei, Jinan, Kunming, Nanning
2026-06-12
Active, closed
Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVI
NCT07658105HCC - Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2
60
Tianjin
2026-06-12
Recruiting
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Not applicable
1,500
Shanghai
2026-06-12
Active, closed
Induction Chemoimmunotherapy Followed by Deescalated Definitive Radiotherapy in Head and Neck Cancer
NCT07791602Head and Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Cancer, HNSCC
DrugCamrelizumab
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
180
Beijing, Harbin, Shenyang, Taiyuan, Tianjin
2026-06-12
Active, closed
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 1
48
Wuhan
2026-06-12
Active, closed
Xi'an Jiaotong University
Not applicable
46
Xi'an
2026-06-11
Recruiting
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
NCT07623369Solid Tumor, Non-small Cell Lung Cancer, Hepatocellular Carcinoma, Colorectal Cancer
Huahui Health
Phase 1
299
Jinan
2026-06-11
Not yet open
Effect of Chinese Herbal Medicine on Kidney Function in Non-Diabetic CKD
NCT07657338Non-diabetic Chronic Kidney Disease
China Medical University Hospital
Not applicable
66
2026-06-11
Recruiting
HAIC Plus QL1706 & Bevacizumab in Unresectable HER2-Negative ICC
NCT07841574Intrahepatic Cholangiocarcinoma
Lianghe Lu
Phase 2
35
Guangzhou
2026-06-11
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
31
Guangzhou
2026-06-11
Recruiting
Hangzhou Sumgen Biotech Co., Ltd.
Phase 2
60
Fuzhou, Guangzhou, Liuzhou, Yulin, Baoding, Chengde, Tangshan, Harbin
2026-06-11
Active, closed
The Clinical Application Value of CAIX-Targeted PET Hypoxia Imaging in Malignant Tumors
NCT07890038Nasopharyngeal Cancers, Lung Cancer (NSCLC), Esophageal Cancer, Glioma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
50
Wuhan
2026-06-11
Recruiting
A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
NCT07646678Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2
DrugTAK-360
Takeda
Phase 2/3
500
Xicheng, Guangzhou, Zhenzhou
2026-06-11
Recruiting
68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma
NCT07590336Hepatocellular Carcinoma (HCC)
Peking Union Medical College Hospital
Phase 1/2
100
Beijing
2026-06-11
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
255
Shanghai
2026-06-11
Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
30
Wuhan
2026-06-11
Recruiting
West China Hospital
Phase 1
9
Chengdu
2026-06-11
Recruiting
Study of D-2570 in Subjects With Non-Segmental Vitiligo
NCT07625891Vitiligo, Non-Segmental Vitiligo (NSV)
InventisBio Co., Ltd
Phase 2
160
Shanghai
2026-06-11
Not yet open
China Medical University Hospital
Not applicable
66
2026-06-11
Recruiting
Innatus Therapeutics (Shanghai) Co., Ltd.
Phase 1/2
24
Guangzhou, Shenyang, Beijing, Hangzhou, Shanghai, Taiyuan, Weifang, Wenzhou
2026-06-11
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Lanzhou, Nanchang, Nanjing
2026-06-11
Recruiting
Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents With Depression
NCT07539805Major Depressive Disorder (MDD), Probiotic Intervention
First Affiliated Hospital of Chongqing Medical University
Phase 2
60
Longgang, Chongqing
2026-06-11
Active, closed
AstraZeneca
Phase 2
326
Beijing, Changsha, Chongqing, Guangzhou, Hangzhou
2026-06-11
Recruiting
Xiamen Amoytop Biotech Co., Ltd.
Phase 2
36
Beijing, Henan, Shanghai, Sichuan, Xiamen, Zhejiang
2026-06-10
Recruiting
Kexing Biopharm Co., Ltd.
Phase 1
18
Beijing
2026-06-10
Not yet open
Beijing Tiantan Hospital
Phase 1
20
Beijing
2026-06-10
Not yet open
Probiotics for Constipation Relief in Adults
NCT07507955Functional Constipation
Wecare Probiotics Co., Ltd.
Not applicable
105
Suzhou
2026-06-10
Recruiting
Xianglin Yuan
Phase 4
32
Wuhan
2026-06-10
Recruiting
yilong Wang
Early Phase 1
20
Beijing
2026-06-10
Not yet open
General Hospital of Ningxia Medical University
Not applicable
80
Yinchuan
2026-06-10
Not yet open
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase 1
12
Hefei
2026-06-10
Recruiting
TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC
NCT07246304Small Cell Lung Cancer ( SCLC ), CAR-T Cell Therapy
DrugsFludarabine·Cyclophosphamide
TCRCure Biopharma Ltd.
Early Phase 1
24
Nanjing
2026-06-10
Not yet open
Xuanzhu Biopharmaceutical Co., Ltd.
Phase 3
556
Shenzhen
2026-06-10
Not yet open
Zhejiang Cancer Hospital
Observational
500
Hangzhou
2026-06-10
Recruiting
Harbin Medical University
Not applicable
150
Fuzhou, Nanning, Shijiazhuang, Harbin, Qiqihar, Wuhan, Baotou, Hohhot
2026-06-10
Recruiting
AstraZeneca
Not applicable
500
Beijing, Cangzhou, Changsha, Chengdu, Chongqing, Guangzhou, Kunming, Quanzhou
2026-06-10
Recruiting
A Digital Cognitive Intervention for Intrusive Memories After Trauma
NCT07523360Post-Traumatic Stress Disorder (PTSD), Intrusive Memories of Traumatic Event(s)
Zhu Zijian
Not applicable
123
Xi'an
2026-06-10
Recruiting
Probiotic Improve Constipation
NCT07462481Constipation
Wecare Probiotics Co., Ltd.
Not applicable
105
Suzhou
2026-06-10
Not yet open
Qilu Hospital of Shandong University
Not applicable
80
Jinan
2026-06-10
Not yet open
Beijing University of Chinese Medicine
Observational
453
Beijing
2026-06-10
Not yet open
Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients
NCT07560475HER2positive, Advanced Breast Cancer, HER2 + Breast Cancer
DrugTrastuzumab Rezetecan
Tianjin Medical University Cancer Institute and Hospital
Phase 2
60
Tianjin
2026-06-10
Active, closed
Harbin Medical University
Phase 2
96
Harbin
2026-06-10
Not yet open
Peking University Shenzhen Hospital
Early Phase 1
10
Shenzhen
2026-06-10
Recruiting
iCell Gene Therapeutics
Phase 1
18
Nanchang
2026-06-10
Recruiting
Shanghai Zhongshan Hospital
Not applicable
420
Chongqing, Fuzhou, Xiamen, Wuhan, Nanjing, Suzhou, Shanghai, Luzhou
2026-06-10
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
30
Hangzhou
2026-06-10
Recruiting
Xuanwu Hospital, Beijing
Observational
1,000
Beijing
2026-06-10
Recruiting
Qilu Pharmaceutical Co., Ltd.
Phase 1
48
Changchun
2026-06-09
Recruiting
Ruijin Hospital
Early Phase 1
60
Shanghai
2026-06-09
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Phase 3
198
Tianjin
2026-06-09
Recruiting
CASI pharmaceuticals, Inc.
Phase 1/2
58
Beijing, Guangzhou, Wuhan, Xi'an
2026-06-09
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2/3
90
Beijing
2026-06-09
Rows per page Showing 2001–2500 of 19187
Previous 3 4 5 6 7 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 8 November 2026. https://priyalifescience.com/clinical-trials-china?page=5

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,790 of the 19,187 studies in this register are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 3,998 have not yet opened recruitment, 2,715 are active but closed to new participants, and 684 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (423) Advanced Solid Tumors (187) Colorectal Cancer (179) Gastric Cancer (175) Hepatocellular Carcinoma (154) Advanced Solid Tumor (153) Non-Small Cell Lung Cancer (145) Solid Tumor (142) Acute Ischemic Stroke (140) Lung Cancer (135) Non-small Cell Lung Cancer (132) Pancreatic Cancer (131) Multiple Myeloma (128) Coronary Artery Disease (122) Prostate Cancer (110)
→

Browse trials by site location

Beijing (5576) Shanghai (3879) Guangzhou (3345) Hangzhou (1819) Wuhan (1343) Chengdu (1307) Nanjing (1211) Changsha (1154) Chongqing (1078) Fuzhou (1040) Tianjin (934) Zhengzhou (931) Hefei (896) Jinan (783) Changchun (639)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.